CA2139132A1 - Nucleosides therapeutiques - Google Patents

Nucleosides therapeutiques

Info

Publication number
CA2139132A1
CA2139132A1 CA002139132A CA2139132A CA2139132A1 CA 2139132 A1 CA2139132 A1 CA 2139132A1 CA 002139132 A CA002139132 A CA 002139132A CA 2139132 A CA2139132 A CA 2139132A CA 2139132 A1 CA2139132 A1 CA 2139132A1
Authority
CA
Canada
Prior art keywords
virus
amino
purine
compound
thio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002139132A
Other languages
English (en)
Inventor
George W. Koszalka
Nanine A. Van Draanen
George A. Freeman
Steven A. Short
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929214171A external-priority patent/GB9214171D0/en
Priority claimed from GB929223180A external-priority patent/GB9223180D0/en
Application filed by Individual filed Critical Individual
Publication of CA2139132A1 publication Critical patent/CA2139132A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002139132A 1992-07-02 1993-07-01 Nucleosides therapeutiques Abandoned CA2139132A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929214171A GB9214171D0 (en) 1992-07-02 1992-07-02 Therapeutic nucleosides
GB9214171.2 1992-07-02
GB929223180A GB9223180D0 (en) 1992-11-05 1992-11-05 Therapeutic nucleosides
GB9223180.2 1992-11-05

Publications (1)

Publication Number Publication Date
CA2139132A1 true CA2139132A1 (fr) 1994-01-20

Family

ID=26301188

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002139132A Abandoned CA2139132A1 (fr) 1992-07-02 1993-07-01 Nucleosides therapeutiques

Country Status (9)

Country Link
EP (1) EP0648218A1 (fr)
JP (1) JPH07508531A (fr)
CN (1) CN1087089A (fr)
AU (1) AU4508593A (fr)
CA (1) CA2139132A1 (fr)
IL (1) IL106204A0 (fr)
MX (1) MX9303985A (fr)
MY (1) MY111746A (fr)
WO (1) WO1994001443A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2224165A1 (fr) * 1996-04-09 1997-10-16 Yamasa Corporation Derives de 9-(2-desoxy-2-fluoro-4-thio-.beta.-d-arabinofuranosyl)purine
US20030008841A1 (en) * 2000-08-30 2003-01-09 Rene Devos Anti-HCV nucleoside derivatives
CN1646141B (zh) * 2000-10-18 2014-06-25 吉利德制药有限责任公司 用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物
CN102924552B (zh) * 2012-11-14 2014-09-10 南京中医药大学 一种具有抗疱疹病毒作用的化合物
CN104497085B (zh) * 2015-01-16 2017-05-24 华东理工大学 腺苷衍生物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234534A (en) * 1989-07-17 1994-12-22 Univ Birmingham Pyrimidine 4'-thionucleoside derivatives and their preparation; intermediates therefor
ES2253732T3 (es) * 1989-09-15 2006-06-01 Southern Research Institute 2'-deoxi-4'-tioribonucleosidos como agentes antivirales y anticancerosos.
IE74701B1 (en) * 1989-10-04 1997-07-30 Univ Birmingham Further antiviral pyrimidine nucleosides

Also Published As

Publication number Publication date
MY111746A (en) 2000-12-30
IL106204A0 (en) 1993-11-15
WO1994001443A1 (fr) 1994-01-20
EP0648218A1 (fr) 1995-04-19
MX9303985A (es) 1994-02-28
CN1087089A (zh) 1994-05-25
JPH07508531A (ja) 1995-09-21
AU4508593A (en) 1994-01-31

Similar Documents

Publication Publication Date Title
FI85978B (fi) Foerfarande foer framstaellning av ett terapeutiskt anvaendbart salt eller ester av 3'-azido-3'deoxitymidin.
CA1314875C (fr) Nucleosides therapeutiques
DE3852531T2 (de) Nukleoside und nukleosid-analoge, pharmazeutische zusammensetzung und verfahren für die herstellung der bestandteile.
DE69933860T2 (de) 2'-fluoronukleoside
US5559101A (en) L-ribofuranosyl nucleosides
KR960002849B1 (ko) 아사이클로비르의 발린 에스테르 및 이를 함유하는 약학 조성물
US8809520B2 (en) Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
JPS63165397A (ja) 抗ウイルス性化合物
AU626284B2 (en) Reverse transcriptase inhibitors for treating adenocarcinomas
DE3875769T2 (de) Therapeutische nukleoside.
CA2348470C (fr) Nucleosides possedant une activite dirigee contre le virus de l'hepatite b
Weis et al. L-ribofuranosyl nucleosides
EP0625158B1 (fr) Nucleosides therapeutiques de la serie 2',3'-dideoxy-3'-fluoro-purine
CA2139132A1 (fr) Nucleosides therapeutiques
US4920210A (en) 2,6-diaminopurine-9-β-D-2',3'-dideoxyribofuranoside
JPH013197A (ja) 抗ウイルス化合物およびそれを含有する抗ウイルス剤
EP0398230B1 (fr) Sels cristallins, stables, antiviraux et bien hydrosolubles de 2',3'-didéoxyinosine monohydrate, 2',3'-didéoxy-2',3'-didehydrothymidine monohydrate et 2',3'-didéoxy-2'-fluoroinosine hémihydrate
WO1996012728A1 (fr) Nucleosides de l-pyranosyle
WO1994001117A1 (fr) Nucleosides therapeutiques
CA2003607A1 (fr) Composes antiviraux
SAIJO et al. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells
RU2237479C2 (ru) Нуклеозиды, обладающие активностью против вируса гепатита в
CA1340519C (fr) Nucleosides antiviraux
WO1993017035A1 (fr) 2'ISO-DIDESOXY-β-D-NUCLEOSIDES UTILES COMME AGENTS ANTIVIRAUX STABLES
CA2203672A1 (fr) Nucleosides de l-ribofuranosyle

Legal Events

Date Code Title Description
FZDE Discontinued